ReachRxResearch
Home
Research
Sign Up
  1. Home
  2. Research Hub
  3. Psychiatric Disorders Before and After I…

Psychiatric Disorders Before and After Inflammatory Bowel Disease Diagnosis: A Nationwide Cohort Study in Sweden 2007 to 2023

Clinical Gastroenterology and Hepatology·August 5Open Access
Gastroenterology & HepatologyPractice changingAnxiety DisordersAutism Spectrum DisorderCrohn'S DiseaseEating DisordersInflammatory Bowel DiseaseMajor Depressive DisorderSubstance Use DisorderUlcerative ColitisMatched Population-Based Cohort StudyAdult

Summary

View source

What was studied

This nationwide Swedish cohort study (2007–2023) examined the temporal pattern of psychiatric disorder risk in 43,862 IBD patients compared with 178,821 matched population controls and IBD-free full siblings, spanning 5 years before to 10 years after IBD diagnosis.

Key findings

Psychiatric disorder risk rose 2–3 years before IBD diagnosis (HR 1.15 at −2 years), peaked at 0.5 years post-diagnosis (HR 1.50, 95% CI 1.41–1.59), and remained elevated at 10 years (HR 1.19, 95% CI 1.13–1.24); major depression, anxiety, and substance misuse drove most of the excess risk, and the sibling-controlled analysis confirmed the risk is not fully explained by shared familial factors.

Study limitations

Psychiatric diagnoses rely on registry data (specialist/inpatient contacts), likely underestimating milder cases managed in primary care. The study is observational and cannot establish causation. Residual confounding from unmeasured environmental factors cannot be excluded despite the sibling-controlled design.

Clinical implications

Screen IBD patients for depression, anxiety, and substance misuse starting at diagnosis and continue monitoring for at least 10 years. Because risk also rises 2–3 years *before* IBD is confirmed, clinicians evaluating new GI symptoms should consider early psychiatric co-assessment.

Related Questions

Explore related topics

What is the best approach to screening for depression and anxiety in IBD patients at diagnosis?Does treating psychiatric comorbidities in IBD improve disease outcomes or quality of life?Are there shared biological mechanisms linking IBD and mood or anxiety disorders?

Publication Details

Year
2026
Journal
Clinical Gastroenterology and Hepatology
Sample Size
n=222,683
Source
View article
Keep scrolling
More content below.
Up Next